There is no official link between microdosing and improved tolerability profiles, as this dosing strategy has not been subjected to controlled clinical trials
All-cause mortality and cardiovascular outcomes with sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes
High Weight Loss Potency Targets hunger and appetite suppression via agents like semaglutide and tirzepatide
The placebo group recorded 0.7%
Copycat products and inadequate oversight: We already have a troubling market of compounded products, research peptides, microdosing plans, longevity packages, and cosmetic weight-loss programs with inadequate medical supervision
Phillips Aesthetics, we are committed to offering advanced, medically supervised weight management solutions to help you look and feel your best